Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

CompletedOBSERVATIONAL

Enrollment

271

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

October 18, 2024

Study Completion Date

October 18, 2024

Conditions

Ulcerative ColitisInflammatory Bowel Diseases

Interventions

DRUG

Infliximab

Infliximab is an antiinflammatory drug (anti-TNF therapy) commonly used in treatment of ulcerative colitis

DRUG

Adalimumab

Adalimumab is an antiinflammatory drug (anti-TNF therapy) commonly used in treatment of ulcerative colitis

Trial Locations (1)

Västra Götalandsregionen, Gothenburg

All Listed Sponsors

lead

Vastra Gotaland Region

OTHER_GOV

NCT06269185 - Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis | Biotech Hunter | Biotech Hunter